Drugs to facilitate recovery of neuromuscular blockade and muscle strength

Journal of Anesthesia

Volumn 19, Issue 4, 2005, Pages 302-308

  Saitoh, Yuhji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Amino acid; Phosphodiesterase III inhibitor; Potassium channel agonist; Protease inhibitor; Vecuronium

Indexed keywords

3 HYDROXY 3 METHYLGLUTARIC ACID; ACETYLCHOLINE; ADENOSINE A1 RECEPTOR; AMINO ACID; AMIPAREN; CROMAKALIM; GABEXATE MESILATE; MILRINONE; NICORANDIL; PHOSPHODIESTERASE III INHIBITOR; PROTEINASE INHIBITOR; ULINASTATIN; VECURONIUM;

ACETYLCHOLINE RELEASE; ACUTE PANCREATITIS; ANESTHETIC RECOVERY; CONTINUOUS INFUSION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; ENERGY RESOURCE; GENERAL ANESTHESIA; HUMAN; HYPOTHERMIA; LIVER CIRRHOSIS; MUSCLE CONTRACTION; MUSCLE STRENGTH; NEUROMUSCULAR BLOCKING; NONHUMAN; PARALYSIS; POTASSIUM CONDUCTANCE; REVIEW; SKELETAL MUSCLE;

AMINO ACIDS; ANESTHESIA RECOVERY PERIOD; ANIMALS; BODY TEMPERATURE REGULATION; HUMANS; MILRINONE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NICORANDIL; PHOSPHODIESTERASE INHIBITORS; POTASSIUM CHANNELS; PROTEASE INHIBITORS; VECURONIUM BROMIDE;

EID: 27944445015     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-005-0336-y     Document Type: Review

References (49)

1. Y Saitoh Y Narumi Y Fujii 1999 Post-tetanic count and train-of-four responses during neuromuscular block produced by vecuronium and infusion of nicardipine Br J Anaesth 83 340-342 10618956
2. K Kawabata K Sumikawa T Kamibayashi T Kita K Takada T Mashimo 1994 Decrease in vecuronium infusion dose requirements by nicardipine in humans Anesth Analg 79 1159-1164 7978442
3. R Jones JN Cashman WR Casson MP Broadbent 1985 Verapamil potentialtion of neuromuscular blockade: Failure of reversal with neostigmine but prompt reversal with edrophonium Anesth Analg 64 1021-1025 4041146
4. H Ohnishi K Suzuki T Niho C Ito K Yamaguchi 1985 Protective effects of urinary trypsin inhibitor in experimental shock Jpn J Pharmacol 39 137-144 2418241
5. K Ota A Namiki I Takahashi H Iwasaki Y Ujike 1989 Effects of ulinastatin on operative stress in major surgery. Masui Jpn J Anesthesiol 38 540-545
6. Y Mizuno K Naoe H Kitagawa H Yamaguchi H Tsunomura M Tan T Kimura T Sakano S Matsumoto S Yoshizaki 1988 Clinical study on the effects of Miracrid® for gastric cancer patients underwent gasterectomy Jpn Pharmacol Ther 16 243-250
7. AL Harvey E Karlsson 1982 Protease inhibitor homologues from mamba venoms: Facilitation of acetylcholine release and interactions with prejunctional blocking toxins Br J Pharmacol 77 153-161 6751453
8. Y Saitoh Y Fujii T Oshima 1999 The ulinastatin-induced effect on neuromuscular block caused by vecuronium Anesth Analg 89 1565-1569 10.1097/00000539-199912000-00048 10589650
9. Y Saitoh K Kaneda M Murakawa 2002 The effect of ulinastatin pre-treatment on vecuronium-induced neuromuscular block in patients with hepatic cirrhosis Anaesthesia 57 218-222 10.1046/ j.0003-2409.2001.02468.x 11879209
10. N Matsumoto K Ohara N Yoshida S Nakamura H Nagasaka K Aikawa T Miyazaki T Hori 1989 Protective effects of ulinastatin on hepatic oxygen metabolism during halothane anesthesia in the presence of graded hypoxic hypoxemia. Masui Jpn J Anesthesiol 38 531-539
11. RA Upton TL Nguyen RD Miller N Castagnoli 1982 Renal and biliary elimination of vecuronium ORG 45 and pancuronium in rats Anesth Analg 61 313-316 6121522
12. AF Bencini AHJ Scaf S Agoston MC Houwertjes UW Kersten 1985 Disposition of vecuronium in the cat Br J Anaesth 57 782-788 2861839
13. C Lebrault JL Berger AA D'Hollander R Gomeri D Henzel P Duvaldestin 1985 Pharmacokinetics pharmacodynamics of vecuronium (ORG NC45) in patients with cirrhosis Anesthesiology 62 601-605 2859815
14. I Aoike Y Takano F Gejyo M Arakawa 1989 Ulinastatin gives rise to an effectual diuresis in oliguric acute renal failure Nephron 52 368-369 2770956
15. MR Fahey RB Morris RD Miller TL Nguyen RA Upton 1981 Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure Br J Anaesth 53 1049-1053 6117300
16. BM Jonsson-Berling K Ohlsson 1991 Distribution and elimination of intravenously injected urinary trypsin inhibitor Scand J Clin Lab Invest 51 549-557 1767247
17. HM Chen TL Hwang MF Chen 1996 The effect of gabexate mesilate on pancreatic and hepatic microcirculation in acute experimental pancreatitis in rats J Surg Res 66 147-153 10.1006/jsre.1996.0387 9024827
18. T Tsuzuki K Toyama K Nakayasu S Iida M Ueda A Toizumi 1990 Disseminated intravascular coagulation after hepatic resection Surgery 107 172-176 2154054
19. N Harada K Okajima S Kushimoto 1999 Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation Crit Care Med 27 1958-1964 10.1097/ 00003246-199909000-00040 10507625
20. YI Kim YJ Hwang KE Song YK Yun JW Lee BY Chun 2002 Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver J Am Coll Surg 195 41-50 10.1016/S1072-7515(01)01118-8 12113544
21. S Ono S Aosasa H Mochizuki 1999 Effects of a protease inhibitor on reduction of surgical stress in esophagectomy Am J Surg 177 78-82 10.1016/S0002-9610(98)00300-6 10037314
22. Hattori H, Saitoh Y, Nakajima H, Sanbe N, Akatu M, Murakawa M (in press) Gabexate masilate hastens recovery from vecuronium-induced neuromuscular blockade. Eur J Anaesthesiol
23. MK Nishijima J Takezawa N Taenaka Y Shimada I Yoshiya 1983 Application of HPLC measurement of plasma concentration of gabexate mesilate Thromb Res 31 279-284 10.1016/0049-3848(83)90330-4 6415853
24. A Mourier AX Bigard E de Kerviler B Roger H Legrand CY Guezennec 1997 Combined effects of caloric restriction and branched-chain amino acid supplementation on body composition and exercise performance in elite wrestlers Int J Sports Med 18 47-55 9059905
25. S Nissen R Sharp M Ray JA Rathmacher D Rice JC Fuller Jr AS Connelly N Abumrad 1996 Effect of leucine metabolite S61538-hydroxy-S61538-methylbutyrate on muscle metabolism during resistance-exercise training J Appl Physiol 81 2095-2104 8941534
26. E Selldén R Bränström T Brundin 1996 Augmented thermic effect of amino acids under general anaesthesia occurs predominantly in extra-splanchnic tissues Clin Sci 91 431-439 8983868
27. Y Saitoh K Kaneda Y Tokunaga M Murakawa 2001 Infusion of amino acid-enriched solution hastens recovery of neuromuscular block caused by vecuronium Br J Anaesth 86 814-821 10.1093/bja/86.6.814 11573589
28. E Selldén SGE Lindahl 1998 Postoperative nitrogen excretion after amino acid-induced thermogenesis under anesthesia Anesth Analg 87 641-646 10.1097/00000539-199809000-00029 9728846
29. E Selldén T Brundin J Wahren 1994 Augmented thermic effect of amino acids under general anaesthesia: A mechanism useful for prevention of anaesthesia-induced hypothermia Clin Sci 86 611-618 8033514
30. MA Konstam RJ Cody 1995 Short-term use of intravenous milrinone for heart failure Am J Cardiol 75 822-826 10.1016/S0002-9149(99)80420-2 7717288
31. Y Fujii S Takahashi H Toyooka 1998 The effects of milrinone and its mechanism in the fatigued diaphragm in dogs Anesth Analg 87 1077-1082 10.1097/00000539-199811000-00018 9806685
32. E Narimatsu Y Nakayama M Aimono N Fujimura H Iwasaki A Namiki 1999 Milrinone, a phosphodiesterase III inhibitor, antagonizes the neuromuscular blocking effect of a non-depolarizing muscle relaxant in vitro Res Commun Mol Pathol Pharmacol 104 219-228 10634314
33. WJ Parsons V Ramkumar GL Stiles 1988 The new cardiotonic agent sulmazole is an A 1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, G i Mol Pharmacol 33 441-448 3128727
34. 1 adenosine receptors and m-cholinoceptors in human myocardium Naunyn Schmiedebergs Arch Pharmacol 341 577-585 10.1007/BF00171739 2392160
35. 1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation Naunyn Schmiedebergs Arch Pharmacol 346 197-202 10.1007/ BF00165301 1333058
36. K Kaibara AG Karczmar 1978 Postsynaptic facilitatory effects of theophylline on amphibian neuromyal transmission J Pharmacol Exp Ther 206 670-676 212547
37. H Nakajima H Hattori K Aoki T Katayama Y Saitoh M Murakawa 2003 Effect of milrinone on vecuronium-induced neuromuscular block Anaesthesia 58 643-646 10.1046/j.1365-2044.2003.03197.x 12790813
38. M Tsunoo S Momomura Y Imai T Uchida 1993 Safety, tolerance and pharmacokinetics of milrinone in phase I study in healthy male Japanese subjects. 2. After intravenous infusion Jpn Pharmacol Ther 21 4659-4679
39. JL Anderson DS Baim SA Fein RA Goldstein TH LeJemtel MJ Likoff 1987 Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: A multicenter study J Am Coll Cardiol 9 711-722 3549837
40. J Utoh Y Miyauchi H Goto H Obayashi T Hirata 1995 Hemodynamic effects of bolus nicorandil compared with nitroglycerin Am J Emerg Med 13 610-612 10.1016/0735-6757(95)90188-4 7662070
41. K Koyama I Kaneko K Mori 1998 The effects of nicorandil on perioperative hemodynamics in CABG patients Anesth Analg 86 S7710.1097/ 00000539-199802001-00077
42. S Murayama T Yamakado T Nakano 1997 Effects of nicorandil, an antianginal potassium channel opener, on left ventricular systolic and diastolic function in patients with chronic coronary artery disease Am J Cardiol 79 1685-1689 10.1016/S0002-9149(97)00225-7 9202366
43. Y Sakata K Kodama K Komamura YJ Lim F Ishikura A Hirayama M Kitakaze T Masuyama M Hori 1997 Salutary effect of adjunctive intracoronary nicorandil administration of restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction Am Heart J 133 616-621 10.1016/S0002-8703(97)70162-5 9200388
44. + channels in mammalian skeletal muscle cells Eur J Pharmacol 236 419-426 10.1016/0014-2999(93)90480-6 8359200
45. EO Weselcouch C Sargent MW Wilde MA Smith 1993 ATP-sensitive potassium channels and skeletal muscle function in vitro J Pharmacol Exp Ther 267 410-416 8229769
46. A Spuler F Lehmann-Horn P Grafe 1989 Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres Naunyn Schiedebergs Arch Pharmacol 339 327-331
47. SJ Hong CC Chang 1991 Hyperpolarization of denervated skeletal muscle by lemakalim and its antagonism by glybenclamide and tolbutamide J Pharmacol Exp Ther 259 932-938 1941637
48. Y Saitoh K Kaneda Y Fujii T Oshima 2001 The effects of nicorandil on neuromuscular block caused by vecuronium Can J Anaesth 48 28-33 11212045
49. A Spuler F Lehmann-Horn P Grafe 1989 Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres Naunyn Schmiedebergs Arch Pharmacol 339 327-331 10.1007/BF00173587 2725710